This is the authors' abstract. We don't add key points for this paper.
A high-performance liquid chromatography with electrochemical detection (HPLC-ECD) system has been developed for determining aristolochic acids I and II (AA1 and AA2). HPLC using an octadecylsilica (ODS) column and a mobile phase of methanol-water-phosphoric acid (65:35:0.5, v/v/v) was conducted for the separation of the AA1 and AA2. Both of the chromatographic peak heights for AA1 and AA2 at the detection potential of −0.7 V vs. Ag/AgCl were found to be linearly related to the concentrations injected, ranging from 10 ng mL−1 to 50 µg mL−1 (r > 0.997). The detection limits (S/N = 3) of AA1 and AA2 were 3.4 and 3.1 ng mL−1, respectively. Considering the detection limits, the present method makes it possible to be a purity test of the quantity of AA1 and AA2 contained as impurities in herbal medicines. The present HPLC-ECD was applied to determine AA1 and AA2 content in Radix et Rhizoma Asari and Radix Aristolochiae Fangchi.
No takes yet. Share an insight, caveat, or question.
Kotani et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: